T. Rowe Price
1937
FOUNDED
PUBLIC
STATUS
5K-10K
EMPLOYEES
TROW
STOCK SYMBOL
247
INVESTMENTS
$111.77
SHARE PRICE
(As of Friday Closing)
Description
Provider of investment management services. The company manages separate client-focused equity, fixed income, and balanced portfolios; common trusts, and institutional mutual funds. It also provides advisory services and invests in the public equity and fixed income markets across the globe. The company provides its services to corporations, corporate, public, and Taft-Hartley retirement plans, foundations and endowments. The company is headquartered in Baltimore, MD.
Website
Formerly Known As
T. Rowe Price Associates
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Brokerage
Stock Exchange
NAS
Primary Office
- 100 East Pratt Street
- Baltimore, MD 21202
- United States
+1 (410) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore T. Rowe Price’s full profile, request a free trial.
T. Rowe Price Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $86.56 - $126.24 | $27.1B | $111.54 | $6.61 | 1.13M | 243M |
T. Rowe Price Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
FY 2015
31-Dec-2015
|
|---|---|---|---|---|
| Enterprise Value | 26,428,342 | 24,907,892 | 17,148,479 | 16,399,929 |
| Revenue | 5,180,800 | 4,793,000 | 4,222,900 | 4,200,600 |
| EBITDA | 2,623,900 | 2,648,700 | 2,093,900 | 2,128,700 |
| Net Income | 1,640,600 | 1,497,800 | 1,215,000 | 1,223,000 |
| Total Assets | 7,882,200 | 7,534,700 | 6,225,000 | 5,106,900 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
T. Rowe Price Investments (247)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 | 21-Sep-2018 | 00000 00000 00 | 00000 | Logistics | |
| 00000000 000000000 | 06-Sep-2018 | 0000 - 0000000 | 00000 | Biotechnology | |
| 000000000 | 06-Sep-2018 | 00000 00000 00 | 0000 | Automation/Workflow Software | 00000 0000000000 |
| 000000 0000000 | 28-Aug-2018 | 00000 00000 00 | 00000 | Diagnostic Equipment | |
| Tempus | 23-Aug-2018 | Later Stage VC | 00000 | Database Software |
T. Rowe Price Exits (121)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000000 | 14-Jun-2017 | 00 000000000000000 | 00.00 | Completed |
|
| 000000000 | 03-Jun-2016 | 00000 00000 00 | 0000 | Completed |
|
| 0000 | 29-Apr-2016 | 00000 00000 00 | 00.000 | Completed |
|
| 000000 000000 0000 | 22-Mar-2016 | 0000 | 00000 | Completed |
|
| Audentes Therapeutics | 08-Oct-2015 | Later Stage VC | 0000 | Completed |
|
T. Rowe Price Executive Team (133)
20 Former Executives
You’re viewing 5 of 133 executives. Get the full list »T. Rowe Price Board Members (15)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000 000000 | Self | Executive Chairman of the Board | 000 0000 | |
| 000000 000000 00 | Self | Board Member | 000 0000 | |
| 0000 00000 0000000000 00 | Self | Board Member | 000 0000 | |
| 00000 000000 | T. Rowe Price | Non-Executive Chairman | 000 0000 | |
| 000000 000000 | Self | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 15 board members. Get the full list »